Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer's disease.
<p>Accumulation of damaged mitochondria is a hallmark of aging and age-related neurodegeneration, including Alzheimer’s disease (AD). The molecular mechanisms of impaired mitochondrial homeostasis in AD are being investigated. Here we provide evidence that mitophagy is impaired in th...
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Nature Research
2019
|
| _version_ | 1826262048112115712 |
|---|---|
| author | Fang, EF Hou, Y Palikaras, K Adriaanse, BA Kerr, JS Yang, B Lautrup, S Hasan-Olive, MM Caponio, D Dan, X Rocktäschel, P Croteau, DL Akbari, M Greig, NH Fladby, T Nilsen, H Cader, MZ Mattson, MP Tavernarakis, N Bohr, VA |
| author_facet | Fang, EF Hou, Y Palikaras, K Adriaanse, BA Kerr, JS Yang, B Lautrup, S Hasan-Olive, MM Caponio, D Dan, X Rocktäschel, P Croteau, DL Akbari, M Greig, NH Fladby, T Nilsen, H Cader, MZ Mattson, MP Tavernarakis, N Bohr, VA |
| author_sort | Fang, EF |
| collection | OXFORD |
| description | <p>Accumulation of damaged mitochondria is a hallmark of aging and age-related neurodegeneration, including Alzheimer’s disease (AD). The molecular mechanisms of impaired mitochondrial homeostasis in AD are being investigated. Here we provide evidence that mitophagy is impaired in the hippocampus of AD patients, in induced pluripotent stem cell-derived human AD neurons, and in animal AD models. In both amyloid-β (Aβ) and tau <em>Caenorhabditis elegans</em> models of AD, mitophagy stimulation (through NAD<sup>+</sup> supplementation, urolithin A, and actinonin) reverses memory impairment through PINK-1 (PTEN-induced kinase-1)-, PDR-1 (Parkinson’s disease-related-1; parkin)-, or DCT-1 (DAF-16/FOXO-controlled germline-tumor affecting-1)-dependent pathways. Mitophagy diminishes insoluble Aβ<sub>1–42</sub> and Aβ<sub>1–40</sub> and prevents cognitive impairment in an APP/PS1 mouse model through microglial phagocytosis of extracellular Aβ plaques and suppression of neuroinflammation. Mitophagy enhancement abolishes AD-related tau hyperphosphorylation in human neuronal cells and reverses memory impairment in transgenic tau nematodes and mice. Our findings suggest that impaired removal of defective mitochondria is a pivotal event in AD pathogenesis and that mitophagy represents a potential therapeutic intervention.</p> |
| first_indexed | 2024-03-06T19:30:12Z |
| format | Journal article |
| id | oxford-uuid:1d30c101-6abf-494b-94b2-baf8375c29d6 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T19:30:12Z |
| publishDate | 2019 |
| publisher | Nature Research |
| record_format | dspace |
| spelling | oxford-uuid:1d30c101-6abf-494b-94b2-baf8375c29d62022-03-26T11:09:35ZMitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer's disease.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:1d30c101-6abf-494b-94b2-baf8375c29d6EnglishSymplectic ElementsNature Research2019Fang, EFHou, YPalikaras, KAdriaanse, BAKerr, JSYang, BLautrup, SHasan-Olive, MMCaponio, DDan, XRocktäschel, PCroteau, DLAkbari, MGreig, NHFladby, TNilsen, HCader, MZMattson, MPTavernarakis, NBohr, VA<p>Accumulation of damaged mitochondria is a hallmark of aging and age-related neurodegeneration, including Alzheimer’s disease (AD). The molecular mechanisms of impaired mitochondrial homeostasis in AD are being investigated. Here we provide evidence that mitophagy is impaired in the hippocampus of AD patients, in induced pluripotent stem cell-derived human AD neurons, and in animal AD models. In both amyloid-β (Aβ) and tau <em>Caenorhabditis elegans</em> models of AD, mitophagy stimulation (through NAD<sup>+</sup> supplementation, urolithin A, and actinonin) reverses memory impairment through PINK-1 (PTEN-induced kinase-1)-, PDR-1 (Parkinson’s disease-related-1; parkin)-, or DCT-1 (DAF-16/FOXO-controlled germline-tumor affecting-1)-dependent pathways. Mitophagy diminishes insoluble Aβ<sub>1–42</sub> and Aβ<sub>1–40</sub> and prevents cognitive impairment in an APP/PS1 mouse model through microglial phagocytosis of extracellular Aβ plaques and suppression of neuroinflammation. Mitophagy enhancement abolishes AD-related tau hyperphosphorylation in human neuronal cells and reverses memory impairment in transgenic tau nematodes and mice. Our findings suggest that impaired removal of defective mitochondria is a pivotal event in AD pathogenesis and that mitophagy represents a potential therapeutic intervention.</p> |
| spellingShingle | Fang, EF Hou, Y Palikaras, K Adriaanse, BA Kerr, JS Yang, B Lautrup, S Hasan-Olive, MM Caponio, D Dan, X Rocktäschel, P Croteau, DL Akbari, M Greig, NH Fladby, T Nilsen, H Cader, MZ Mattson, MP Tavernarakis, N Bohr, VA Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer's disease. |
| title | Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer's disease. |
| title_full | Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer's disease. |
| title_fullStr | Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer's disease. |
| title_full_unstemmed | Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer's disease. |
| title_short | Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer's disease. |
| title_sort | mitophagy inhibits amyloid β and tau pathology and reverses cognitive deficits in models of alzheimer s disease |
| work_keys_str_mv | AT fangef mitophagyinhibitsamyloidbandtaupathologyandreversescognitivedeficitsinmodelsofalzheimersdisease AT houy mitophagyinhibitsamyloidbandtaupathologyandreversescognitivedeficitsinmodelsofalzheimersdisease AT palikarask mitophagyinhibitsamyloidbandtaupathologyandreversescognitivedeficitsinmodelsofalzheimersdisease AT adriaanseba mitophagyinhibitsamyloidbandtaupathologyandreversescognitivedeficitsinmodelsofalzheimersdisease AT kerrjs mitophagyinhibitsamyloidbandtaupathologyandreversescognitivedeficitsinmodelsofalzheimersdisease AT yangb mitophagyinhibitsamyloidbandtaupathologyandreversescognitivedeficitsinmodelsofalzheimersdisease AT lautrups mitophagyinhibitsamyloidbandtaupathologyandreversescognitivedeficitsinmodelsofalzheimersdisease AT hasanolivemm mitophagyinhibitsamyloidbandtaupathologyandreversescognitivedeficitsinmodelsofalzheimersdisease AT caponiod mitophagyinhibitsamyloidbandtaupathologyandreversescognitivedeficitsinmodelsofalzheimersdisease AT danx mitophagyinhibitsamyloidbandtaupathologyandreversescognitivedeficitsinmodelsofalzheimersdisease AT rocktaschelp mitophagyinhibitsamyloidbandtaupathologyandreversescognitivedeficitsinmodelsofalzheimersdisease AT croteaudl mitophagyinhibitsamyloidbandtaupathologyandreversescognitivedeficitsinmodelsofalzheimersdisease AT akbarim mitophagyinhibitsamyloidbandtaupathologyandreversescognitivedeficitsinmodelsofalzheimersdisease AT greignh mitophagyinhibitsamyloidbandtaupathologyandreversescognitivedeficitsinmodelsofalzheimersdisease AT fladbyt mitophagyinhibitsamyloidbandtaupathologyandreversescognitivedeficitsinmodelsofalzheimersdisease AT nilsenh mitophagyinhibitsamyloidbandtaupathologyandreversescognitivedeficitsinmodelsofalzheimersdisease AT cadermz mitophagyinhibitsamyloidbandtaupathologyandreversescognitivedeficitsinmodelsofalzheimersdisease AT mattsonmp mitophagyinhibitsamyloidbandtaupathologyandreversescognitivedeficitsinmodelsofalzheimersdisease AT tavernarakisn mitophagyinhibitsamyloidbandtaupathologyandreversescognitivedeficitsinmodelsofalzheimersdisease AT bohrva mitophagyinhibitsamyloidbandtaupathologyandreversescognitivedeficitsinmodelsofalzheimersdisease |